Erno Laszlo acquired by RBS private equity
Former Molton Brown ceo Charles Denton to partner
The brand has been owned by Fox Paine since 2002, during which time it enjoyed significant investment driving new product development and international expansion.
Linsdey McMurray, head of RBS Equity Finance said: “Erno Laszlo is a unique luxury proposition with a discerning loyal following. We believe it is well positioned to take advantage of the growing demand for premium anti-ageing products with proven efficacy.”
RBS Equity Finance will be the sole institutional investor in Erno Laszlo and is partnering with Charles Denton, former ceo of Molton Brown, who successfully led that brand’s transformation from a single hairdressing boutique in Mayfair into a global premium business.
Denton commented: “I’m incredibly excited about the partnership with RSB Equity Finance and our acquisition of this exceptional beauty brand. The extraordinary heritage and iconic status of Laszlo will provide a wonderful foundation as we seek to expand the business globally.”
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more. -
You need to be a subscriber to read this article.
Click here to find out more. -
You need to be a subscriber to read this article.
Click here to find out more. -
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
![Inside Dermalogica’s big innovation plans: longevity science, AI and biotechnology]()
Inside Dermalogica’s big innovation plans: longevity science, AI and biotechnology
The Unilever-owned heritage player’s innovation pipeline for the next two years sees it ramp up R&D in longevity science, AI-designed functional peptides, sun care filters and biotechnology to ensure better skin barrier health
Colour Cosmetics
![Has Estée Lauder Companies decided against selling Dr. Jart+, Too Faced and Smashbox?]()
Has Estée Lauder Companies decided against selling Dr. Jart+, Too Faced and Smashbox?
After months of speculation that Estée Lauder Companies was allegedly mulling a potential sale of Too Faced, Smashbox and Dr. Jart+, a new report alleges the beauty giant has decided to keep the trio in its portfolio
Ingredients
![Nanyang Biologics (NYB) and Sweetch Group partner to advance AI-powered discovery of nature-derived cosmetic ingredients]()
Nanyang Biologics (NYB) and Sweetch Group partner to advance AI-powered discovery of nature-derived cosmetic ingredients
Nanyang Biologics (NYB) and Sweetch Group, through its subsidiary Laboratoire Greenpharma, today announced a strategic collaboration to accelerate the discovery and development of next-generation nature-derived bioactive ingredients for skincare and cosmetics
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
![Updated: Olaplex to 111Skin – All the beauty M&A deals of 2026 so far]()
Updated: Olaplex to 111Skin – All the beauty M&A deals of 2026 so far
Estée Lauder Companies, L’Oréal, Unilever and Henkel are among the beauty giants bolstering their portfolio with acquisitions such as 111Skin, Innovist, Grüns and Olaplex in a busy first half of the year for beauty M&A
Manufacturing
![Brabender TwinLab B-TSE-S 30/40: Pilot-scale extrusion with lab-level insight]()
Brabender TwinLab B-TSE-S 30/40: Pilot-scale extrusion with lab-level insight
With throughput up to 100 kg/h, the new twin-screw extruder brings lab-grade process understanding into pilot-scale production, enabling users to validate process parameters and produce relevant quantities under realistic conditions